Published 21 October 2008, doi:10.1136/bmj.a2200
Cite this as: BMJ 2008;337:a2200

News

US university sets up conflict of interest office after investigation into drug company payments

¹ New York

The first 150 words of the full text of this article appear below.

Emory University in Atlanta, Georgia, said that it was setting up a new office to oversee conflict of interest issues.

The US Senate Finance Committee is investigating Charles Nemeroff, chairman of the university’s department of psychiatry and behavioural sciences, for allegedly not reporting payments from drug companies.

The university said that the new central office "will help us ensure strong conflict of interest policies and procedures university-wide."

The National Institutes of Health froze a $9.3m (£5.4m; 6.9m), five year grant to Dr Nemeroff on 15 August. Dr Nemeroff temporarily stepped down as department chairman, although he remains a professor.

Emory University received $411m in research funding last year, of which $251m came from the National Institutes of Health (NIH), said a university spokesman, Jeffrey Molter.

The university told its researchers about new rules on financial disclosure for those working under new and pending grants from NIH. The university’s new office . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

US senators inquire into ties between stent makers and doctors

Janice Hopkins Tanne
BMJ 2008 337: a2363. [Extract] [Full Text]

US psychiatrist steps down after questions about drug company payments

Janice Hopkins Tanne
BMJ 2008 337: a2088. [Extract] [Full Text]

Online poll

Find out more here>> and here>>